C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) A61K 31/70 (2006.01) A61K 31/7088 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) C12N 15/11 (2006.01) C12N 15/18 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2214431
Disclosed are oligonucleotides complementary to VEGF-specific nucleic acid useful in reducing the expression of VEGF. Also disclosed are pharmaceutical formulations containing such oligonucleotides and method useful for treating various disorders associated with neovascularization and angiogenesis.
L'invention concerne des oligonucléotides complémentaires de l'acide nucléique spécifique du facteur de croissance de l'endothélium vasculaire utiles dans la réduction de l'expression dudit facteur de croissance. L'invention concerne également des formulations pharmaceutiques contenant ces oligonucléotides et un procédé utile pour traiter divers troubles associés à la néoformation de vaisseaux sanguins et à l'angiogénèse.
Hybridon Inc.
Idera Pharmaceuticals Inc.
Mbm Intellectual Property Law Llp
LandOfFree
Human vegf-specific antisense oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human vegf-specific antisense oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human vegf-specific antisense oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1965624